David Charles Blakey

Person

Macclesfield Cheshire, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 10,066,011
- Issue date Sep 4, 2018
- MedImmune Limited
- Larry L. Green
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 8,834,880
- Issue date Sep 16, 2014
- MedImmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents directed to PDGRF-alpha and uses thereof
- Patent number 8,697,664
- Issue date Apr 15, 2014
- MedImmune Limited
- Naomi Laing
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to angiopoietin-2 and uses thereof
- Patent number 7,973,140
- Issue date Jul 5, 2011
- MedImmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents directed to PDGFR-alpha and uses thereof
- Patent number 7,754,859
- Issue date Jul 13, 2010
- AstraZeneca AB
- Naomi Laing
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives with vascular damaging activity
- Patent number 7,030,123
- Issue date Apr 18, 2006
- Astrazeneca AB
- Jean-Claude Arnould
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 6,436,691
- Issue date Aug 20, 2002
- Zeneca Limited
- Anthony Michael Slater
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene construct encoding a heterologous prodrug-activating enzyme an...
- Patent number 6,339,070
- Issue date Jan 15, 2002
- Zeneca Limited
- Stephen Charles Emery
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 5,985,281
- Issue date Nov 16, 1999
- Zeneca Limited
- Christopher John Taylorson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies recognizing tumor associated antigen CA 55.1
- Patent number 5,665,357
- Issue date Sep 9, 1997
- Zeneca Limited
- Michael Samuel Rose
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20160251421
- Publication date Sep 1, 2016
- MEDIMMUNE LIMITED
- Jeffrey Lester BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF
- Publication number 20150125455
- Publication date May 7, 2015
- MEDIMMUNE LIMITED
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20140023654
- Publication date Jan 23, 2014
- MEDIMMUNE LIMITED
- Jeffrey Lester BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF
- Publication number 20130171160
- Publication date Jul 4, 2013
- MEDIMMUNE LIMITED
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20120288497
- Publication date Nov 15, 2012
- MEDIMMUNE LIMITED
- DAVID CHARLES BLAKEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to Angiopoietin-2 And Uses Thereof
- Publication number 20120052073
- Publication date Mar 1, 2012
- Medlmmune Limited
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to CD20 and Uses Thereof
- Publication number 20110129412
- Publication date Jun 2, 2011
- AstraZeneca AB
- Gadi Gazit-Bornstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20110097321
- Publication date Apr 28, 2011
- AstraZeneca AB
- David Charles Blakey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO PDGRF-ALPHA AND USES THEREOF
- Publication number 20110020360
- Publication date Jan 27, 2011
- AstraZeneca AB
- NAOMI LAING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF
- Publication number 20090324601
- Publication date Dec 31, 2009
- AstraZeneca AB
- David Charles Blakey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...
- Publication number 20090123474
- Publication date May 14, 2009
- AstraZeneca AB
- David Charles Blakey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to Angiopoietin-2 and Uses Thereof
- Publication number 20080267971
- Publication date Oct 30, 2008
- Larry L. Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF
- Publication number 20080089837
- Publication date Apr 17, 2008
- Naomi LAING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to CD20 and uses thereof
- Publication number 20070014720
- Publication date Jan 18, 2007
- Gadi Gazit-Bornstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to angiopoietin-2 and uses thereof
- Publication number 20060246071
- Publication date Nov 2, 2006
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Indole derivatives with vascular damaging activity
- Publication number 20030216356
- Publication date Nov 20, 2003
- Jean-Claude Arnould
- C07 - ORGANIC CHEMISTRY

David Charles Blakey

Person

Patents Grantslast 30 patents

Antibodies directed to angiopoietin-2 and uses thereof

Antibodies directed to angiopoietin-2 and uses thereof

Targeted binding agents directed to PDGRF-alpha and uses thereof

Antibodies directed to angiopoietin-2 and uses thereof

Targeted binding agents directed to PDGFR-alpha and uses thereof

Indole derivatives with vascular damaging activity

Chemical compounds

Gene construct encoding a heterologous prodrug-activating enzyme an...

Chemical compounds

Antibodies recognizing tumor associated antigen CA 55.1

Patents Applicationslast 30 patents

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

Antibodies Directed to Angiopoietin-2 And Uses Thereof

Antibodies Directed to CD20 and Uses Thereof

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

TARGETED BINDING AGENTS DIRECTED TO PDGRF-ALPHA AND USES THEREOF

TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR...

Antibodies Directed to Angiopoietin-2 and Uses Thereof

TARGETED BINDING AGENTS DIRECTED TO PDGFR-ALPHA AND USES THEREOF

Antibodies directed to CD20 and uses thereof

Antibodies directed to angiopoietin-2 and uses thereof

Indole derivatives with vascular damaging activity